J1458 HCPCS Level II Code: Injection, galsulfase, 1 mg
Medicare Coverage & Payment
- CMS short descriptor: Galsulfase injection
- Medicare coverage: Carrier judgment (CMS coverage code C)
- Payment category: Drugs (pricing indicator 51)
- BETOS: O1E — Other drugs
- Last CMS action effective: January 1, 2024
Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.
Change history
- January 1, 2007Added to the code setInjection, galsulfase, 1 mg
Drug products (NDC)
CMS ASP NDC-HCPCS Crosswalk · 2026 Q3
Medicare Part B payment limit (ASP + 6%): $525.97
68135-0020-01 — Naglazyme — BioMarin Pharmaceutical Inc. (size 1 × qty 1 (1 MG per billing unit))
From the CMS ASP NDC-HCPCS Crosswalk and Part B Payment Limit File. Payment limits apply per HCPCS billing code, not per package.
Contextual Map
Every relationship of J1458 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Nearest codes (35)
- J1410 — Injection, estrogen conjugated, per 25 mg[Sibling]
- J1411 — Injection, etranacogene dezaparvovec-drlb, per therapeutic dose[Sibling]
- J1412 — Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes[Sibling]
- J1413 — Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose[Sibling]
- J1414 — Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose[Sibling]
- J1426 — Injection, casimersen, 10 mg[Sibling]
- J1427 — Injection, viltolarsen, 10 mg[Sibling]
- J1428 — Injection, eteplirsen, 10 mg[Sibling]
- and 27 more
Change history
- January 1, 2007 — Added to the code set [Change history]
Nearest Codes in This Family
Official HCPCS Level II classifications closest to J1458 in its code family, with their registry titles.
- J1450 — Injection fluconazole, 200 mg
- J1451 — Injection, fomepizole, 15 mg
- J1452 — Injection, fomivirsen sodium, intraocular, 1.65 mg
- J1453 — Injection, fosaprepitant, 1 mg
- J1454 — Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
- J1455 — Injection, foscarnet sodium, per 1000 mg
- J1456 — Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg
- J1457 — Injection, gallium nitrate, 1 mg
- J1459 — Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1460 — Injection, gamma globulin, intramuscular, 1 cc